ClariVest Asset Management’s Intersect ENT, Inc XENT Stock Holding History

ClariVest Asset Management’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-5,421	Closed	-$153K	–	805
2018 Q4	$153K	Sell	5,421 -1,112	-17%	-$32.6K	﹤0.01%	572
2018 Q3	$188K	Sell	6,533 -3,458	-35%	-$104K	﹤0.01%	590
2018 Q2	$375K	Hold	9,991	–	–	0.01%	531
2018 Q1	$392K	Buy	9,991 +998	+11%	+$36.5K	0.01%	523
2017 Q4	$291K	Hold	8,993	–	–	0.01%	547
2017 Q3	$280K	Buy	8,993 +348	+4%	+$10.3K	0.01%	451
2017 Q2	$241K	Hold	8,645	–	–	0.01%	458
2017 Q1	$148K	Buy	+8,645	New	+$121K	﹤0.01%	514

Other funds holding XENT

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

ClariVest Asset Management's XENT Position: Q1 2019 in Review

ClariVest Asset Management sold out of Intersect ENT, Inc (XENT) in Q1 2019, closing a stake of 5,421 shares — an estimated $153K sold.

ClariVest Asset Management first reported a position in XENT in Q1 2017 and held it in 8 quarters. The position peaked at $392K in Q1 2018. 136 funds tracked by Wall St. Rank hold XENT as of Q1 2019.

ClariVest Asset Management reported no remaining Intersect ENT, Inc position as of Q1 2019 after selling out during the quarter.
ClariVest Asset Management sold 5,421 Intersect ENT, Inc shares in Q1 2019, an estimated $153K.
ClariVest Asset Management first reported a position in Intersect ENT, Inc in Q1 2017 and held it in 8 quarters.
ClariVest Asset Management's Intersect ENT, Inc position peaked at $392K in Q1 2018.
136 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q1 2019.

Based on ClariVest Asset Management's 13F filing for Q1 2019, filed 13 May 2019.